Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells

References

• Mehta N, Hordines J, Volpe C, Doerr R, Cohen SA. Cellular effects of hypercholesterolemia in modulation of cancer growth and metastasis: a review of evidence. Surg Oncol 1997; 7: 179–86
   Google Scholar
• Rao KN. The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis [review]. Anticancer Res 1995; 15: 309–14
   PubMed Web of Science ®Google Scholar
• Coleman PS, Laviets BB. Membrane cholesterol and tumorigenesis. CRC Crit Rev Biochem 1981; 11: 341–93
   PubMed Web of Science ®Google Scholar
• Caruso MG, Osella AR, Notarnicola M, Berloco P, Leo S, Bonfiglio C, et al. Prognostic value of low density lipoprotein receptor expression in colorectal carcinoma. Oncol Rep 1998; 5: 927–30
   PubMedGoogle Scholar
• Caruso MG, Notarnicola M, Santillo M, Cavallini A, Di Leo A. Enhanced 3-hydroxy-3-methyl-glutaryl coenzyme A reductase activity in human colorectal cancer not expressing low density lipoprotein receptor. Anticancer Res 1999; 19: 451–4
   PubMed Web of Science ®Google Scholar
• Rao KN, Elm MS, Kelly RH, Chandar N, Brady EP, Rao B, et al. Hepatic hyperplasia and cancer in rats: metabolic alterations associated with cell growth. Gastroenterology 1997; 113: 238–48
   PubMed Web of Science ®Google Scholar
• Fabricant M, Broitman SA. Evidence for deficiency of low density lipoprotein receptor on human colonic carcinoma cell lines. Cancer Res 1990; 50: 632–6
   PubMed Web of Science ®Google Scholar
• Di Croce L, Bruscalupi G, Trentalance A. Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment. Biochem Biophys Res Comm 1996; 224: 345–50
   PubMedGoogle Scholar
• Di Stefano E, Marino M, Gillette JA, Hanstein B, Pallottini V, Bruning J, et al. Role of tyrosine kinase signaling in estrogen-induced LDL receptor gene expression in HepG2 cells. Biochim Biophys Acta 2002; 1580: 145–9
   PubMedGoogle Scholar
• Borradaile NM, De Dreu LE, Wilcox LJ, Edwards JY, Huff MW. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem J 2002; 366: 531–9
   PubMed Web of Science ®Google Scholar
• Di Leo A, Messa C, Cavallini A, Linsalata M. Estrogens and colorectal cancer. Current Drug Targets-Immune. Endocr Metab Dis 2001; 1: 1–12
   Google Scholar
• Grondstein F, Newcomb PA, Stampler MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106: 574–83
   PubMedGoogle Scholar
• Al-Azzawi F, Wahab M. Estrogen and colon cancer: current issues. Climateric 2002; 5: 3–14
   PubMed Web of Science ®Google Scholar
• Xu X, Thomas ML. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endocrinol 1994; 105: 197–201
   PubMed Web of Science ®Google Scholar
• Singh S, Paraskeva C, Gallimore PH, Sheppard MC, Langman MJS. Differential growth response to oestrogen of premalignant and malignant colonic cell lines. Anticancer Res 1994; 14: 1037–42
   PubMed Web of Science ®Google Scholar
• Di Domenico M, Castoria G, Bilancio A, Migliaccio A, Auricchio F. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 1996; 56: 4516–21
   PubMed Web of Science ®Google Scholar
• Di Leo A, Messa C, Russo F, Misciagna G, Guerra V, Taveri R, et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig Dis Sci 1994; 39: 2038–42
   PubMedGoogle Scholar
• Russo F, Linsalata M, Messa C, Cavallini A, Notarnicola M, Guerra V, et al. Polyamines and estrogen-receptor concentrations in human colorectal carcinomas. Ital J Gastroenterol 1992; 24: 8–12
   PubMedGoogle Scholar
• Messa C, Pricci M, Linsalata M, Russo F, Di Leo A. Inhibitory effect of 17β-estradiol on growth and the polyamine metabolism of a human gastric carcinoma cell line (HGC-27). Scand J Gastroenterol 1999; 34: 79–84
   PubMed Web of Science ®Google Scholar
• Messa C, Russo F, Pricci M, Di Leo A. Epidermal growth factor and 17β-estradiol effects on proliferation of a human gastric cancer cell lines (AGS). Scand J Gastroenterol 2000; 35: 753–8
   PubMed Web of Science ®Google Scholar
• Fiorelli G, Picariello V, Martinetti F, Tonelli F, Brandi ML. Functional estrogen receptor β in colon cancer cells. Biochem Biophys Res Commun 1999; 261: 521–7
   PubMed Web of Science ®Google Scholar
• Bocchetta M, Bruscalupi G, Castellano F, Trentalance A, Komaromy M, Fong LG, et al. Early induction of LDL receptor gene during rat liver regeneration. J Cell Physiol 1993; 156: 601–9
   PubMedGoogle Scholar
• Lamon-Fava S, Ordovas JM, Schaefer EJ. Estrogen increases apolipoprotein (Apo) A-I in Hep G2 cells by modulating transcription of the apo A-I gene promoter. Arterioscler Thromb Vasc Biol 1999; 19: 2960–5
   PubMedGoogle Scholar
• Lowry OH, Rosembrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Caruso MG, Notarnicola M, Bifulco M, Laezza C, Guerra V, Altomare DF, et al. Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation. Scand J Gastroenterol 2003; 38: 80–5
   PubMed Web of Science ®Google Scholar
• Siperstein MD. Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res 1984; 25: 1462–8
   PubMed Web of Science ®Google Scholar
• Clarke S. Protein isoprenylation and methylation at carboxyl-terminal cystein residue. Annu Rev Biochem 1992; 61: 355–86
   PubMed Web of Science ®Google Scholar
• Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr 1999; 129: 775S–8S
   PubMed Web of Science ®Google Scholar
• Crick DC, Andres DA, Danesi R, Macchia M, Waechter CJ. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells. J Neurochem 1998; 70: 2397–405
   PubMed Web of Science ®Google Scholar
• Castellano F, Bruscalupi G, Colomba S, Di Croce L, Trentalance A, Augusti-Tocco G. Characterisation of the response of growth and differentiation to lipoprotein and agents affecting cholesterol metabolism in murine neuroblastoma cells. Int J Dev Neurosci 1994; 12: 77–84
   PubMedGoogle Scholar
• Marino M, Distefano E, Pallottini V, Caporali S, Bruscalupi G, Trentalance A. Activation of IP3-protein kinase C-α signal transduction pathway precedes the change of plasma cholesterol, hepatic lipid metabolism and induction of low-density lipoprotein receptor expression in 17-β-oestradiol-treated rats. Exp Physiol 2001; 86: 139–45
   Google Scholar
• Gil G, Faust JR, Chin DJ, Goldstein JL, Brown MS. Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme. Cell 1985; 41: 249–58
   PubMed Web of Science ®Google Scholar
• Sever N, Song BL, Yabe D, Goldstein JL, Brown MS, DeBose-Boyd RA. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 2003; 278: 52479–90
   PubMed Web of Science ®Google Scholar
• Notarnicola M, Messa C, Cavallini A, Bifulco M, Tecce MF, Eletto D, et al. Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis. Oncology 2004; 67: 351–8
   PubMed Web of Science ®Google Scholar
• Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, et al. Phase I study of Lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 1996; 2: 483–91
   PubMed Web of Science ®Google Scholar
• Notarnicola M, Messa C, Pricci M, Guerra V, Altomare DF, Montemurro S, et al. Up-regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in left-sided human colon cancer. Anticancer Res 2004; 24: 3837–42
   PubMed Web of Science ®Google Scholar